ロード中...
Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds
T cells that are genetically engineered to express chimeric antigen receptors (CAR T cells) have shown impressive clinical efficacy against B‐cell malignancies. In contrast to these highly potent CD19‐targeting CAR T cells, many of those directed against other tumor entities and antigens currently s...
保存先:
| 出版年: | FEBS J |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8048499/ https://ncbi.nlm.nih.gov/pubmed/32794303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15523 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|